Fundz

Greenwich Life Sciences reported raising $2.5 Million in an initial SEC Form D filing, from an offering of $2.5 Million

PUBLIC · GLSIJun 18, 2024

Amount Raised

$2.5 Million

$2.5 Million sold, per SEC Form D (first sale Jun 13, 2024)

Round Type

Seed

StaffordBiotechnology

Quick answer

Greenwich LifeSciences raised $2.5 Million in a Seed round, dated June 13, 2024. Greenwich LifeSciences is based in Stafford, Texas, United States.

How much did Greenwich LifeSciences raise?
Greenwich LifeSciences raised $2.5 Million in a Seed round on June 13, 2024.
What does Greenwich LifeSciences do?
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a clinical-stage public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced Flamingo-01, a..
Where is Greenwich LifeSciences based and how big is it?
Greenwich LifeSciences is based in Stafford, Texas, United States.
Who are the decision-makers at Greenwich LifeSciences?
Fundz holds 1 contact at Greenwich LifeSciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Greenwich LifeSciences that raised within 45 days of this round, from Fundz verified event records.

  • Axe Compute Inc. raised $2.2M on July 26, 2024.
  • Revi R Therapeutics raised $30M (Series A) on July 26, 2024.
  • Amporin Pharmaceuticals raised $170K (Grant) on July 26, 2024.
  • Confo Therapeutics raised $65M (Series B) on July 26, 2024.
  • 4D Medicine raised $4.4M (Series A) on July 26, 2024.
  • Endolytix Technology raised $5M on July 26, 2024.

Who to call at Greenwich LifeSciences, and when

A new round usually means Greenwich LifeSciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Greenwich LifeSciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Greenwich LifeSciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Greenwich LifeSciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Greenwich LifeSciences

Location

3992 BLUEBONNET DR

Stafford, Texas, United States

About

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a clinical-stage public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced Flamingo-01, a Phase III clinical trial, with plans to expand from the US into Europe and to open up to 150 sites globally. Flamingo-01 is designed to evaluate the safety and efficacy of GLSI-100 in HER2/neu positive patients with residual disease or high-risk pathologic complete response at surgery and who have completed both neoadjuvant and postoperative adjuvant trastuzumab based treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Greenwich LifeSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Greenwich LifeSciences's next move

See what Strategic adds

Greenwich LifeSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.